MSH2 and MLH1, but also MSH6 and PMS2 are the most common pathogenetic variants [2,3,4,9,10,11,12] determining MMR deficiency in tumoral tissue; this is due to altered MMR protein functionality. The gene discussed is MRC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.